Journals / Ege Tıp Dergisi / 2020 / Cilt: 59 - Sayı: 0

Epidemiological and demographic characteristics of non-melanoma skin cancers in Ege University Hospital

Ege Üniversitesi Hastanesinde görülen melanom dışı deri kanserlerinin epidemiyolojik ve demografik özellikleri

Pages
97–108
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The group with the youngest mean age was cutaneous lymphomas, while the older age group was squamous cell carcinoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We aimed to evaluate the epidemiological characteristics of patients diagnosed as nonmelanoma skin cancer in the database of Ege University Hospital between 1992-2017.
📊
Key Findings & Data:Materials and Methods: The data of 8395 patients diagnosed with non-melanoma skin cancer enrolled at Ege University between 1992-2017, recorded by the CANREG 4 program by specially trained and certified cancer registry staff of the Ege University Cancer Control Research and Application Center, were collected and evaluated in terms of age, sex, histopathological diagnosis of the tumor, tumor location, disease stage and treatment methods.
💡
Conclusion & Impact:The group with the youngest mean age was cutaneous lymphomas, while the older age group was squamous cell carcinoma.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: We aimed to evaluate the epidemiological characteristics of patients diagnosed as nonmelanoma skin cancer in the database of Ege University Hospital between 1992-2017. Materials and Methods: The data of 8395 patients diagnosed with non-melanoma skin cancer enrolled at Ege University between 1992-2017, recorded by the CANREG 4 program by specially trained and certified cancer registry staff of the Ege University Cancer Control Research and Application Center, were collected and evaluated in terms of age, sex, histopathological diagnosis of the tumor, tumor location, disease stage and treatment methods. While the existence of the relationship between categorical variables was evaluated with the Chi-Square method, the numerical variables between the groups were compared with the Kruskal Wallis and Dunn Test. All Hypothesis tests were applied at 0.05 significance level. Results: 8386 of 8395 patients with non-melanoma skin cancer registered between 1992 and 2017 at the Cancer Research Center of Ege University were included. Of 55.9% patients had basal cell carcinoma, 30.3% had squamous cell carcinoma, 3.6% had malignant cutaneous soft tissue tumor , 3.4% had basosquamous carcinoma, 2.7% had cutaneous lymphoma, 1.4% had malignant cutaneous adnexal tumors, 0.4% had Merkel cell carcinoma and 2.3% had unclassified tumor. Of 57.3% patients were male and 42.7% were female. The average age was 63.3 ± 14.3. Conclusions: In our study most of the cases were epithelial carcinomas. The most common cancer was basal cell carcinoma, followed by squamous cell carcinoma. The least common tumor was the Merkel cell carcinoma. Except Merkel cell carcinoma, the male sex was more dominant. The group with the youngest mean age was cutaneous lymphomas, while the older age group was squamous cell carcinoma.

Özet

Amaç: Bu çalışmada Ege Üniversitesi Hastanesi veri tabanındaki 1992-2017 yılları arası melanom dışı malign deri kanseri tanısı alan hastaların epidemiyolojik ve demografik özelliklerinin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Ege Üniversitesi Kanserle Savaş Araştırma ve Uygulama Merkezinin özel eğitimli ve sertifikalı kanser kayıt elemanları tarafından CANREG 4 programı ile kaydedilen 1992-2017 yılları arasında Ege Üniversitesinde kayıtlı 8395 melanom dışı malign deri kanseri tanılı hastanın; tanı yaşı, cinsiyeti, tümörün histopatolojik tanısı, tümör yerleşim yeri, hastalık evresi ve uygulanan tedavi yöntemleri değerlendirilmiştir. Kategorik değişkenler arası ilişki varlığı Ki-Kare yöntemiyle değerlendirilirken, gruplar arası nümerik değişkenler Kruskal Wallis ve Dunn Testi ile karşılaştırıldı. Tüm Hipotez testleri 0,05 önem seviyesinde uygulandı. Bulgular: Ege Üniversitesi Kanser Araştırma Merkezinde 1992 ile 2017 yılları arasında kayıtlı melanom dışı deri kanseri olan 8395 hastanın 8386’sı dahil edildi. Hastaların %55,9’unda bazal hücreli karsinom, %30,3’ünde skuamoz hücreli karsinom, %3,6’sında malign kutanöz yumuşak doku tümörü, %3,4’ünde bazoskuamoz karsinom, %2,7’sinde kutanöz lenfoma, %1,4’ünde malign deri eki tümörü, %0,4’ünde Merkel hücreli karsinom, %2,3’ünde sınıflandırılamayan tümör mevcuttu. Hastaların %57,3’ü erkek, %42,7’si kadındı. Yaş ortalaması 63,3±14,3 idi. Sonuçlar: Olguların çoğunu epitelyal karsinomlar oluşturmakta idi. Çalışmada en sık görülen kanser tipi bazal hücreli karsinomdu ve bunu ikinci sırada skuamoz hücreli karsinom izlemekteydi. En az görülen Merkel hücreli karsinomdu. Merkel hücreli karsinom dışında erkek cinsiyet daha baskındı. Yaş ortalaması en genç olan grup kutanöz lenfomalarken, en ileri yaş gruplu tümör skuamoz hücreli karsinomdu.

🔖

Cite This Article

ACAR, A., YAMAN, B., YANMAZ, A., YOLDAŞ, A. H., KARAARSLAN, I., AKALIN, T., ÖZDEMİR, F., TÜRK, B. G., CANER, A., KANDİLOĞLU, G., HAYDAROĞLU, A., CEYLAN, C. (2020). Epidemiological and demographic characteristics of non-melanoma skin cancers in Ege University Hospital. Ege Tıp Dergisi, Cilt: 59 - Sayı: 0, 97–108. https://ajindex.com/articles/152095

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D. Epidemiological trends in skin cancer. Dermatol Pract Concept. 2017;7(2):1-6
  2. Motaparthi K, Kapil JP, Velazquez EF. Cutaneous Squamous Cell Carcinoma: Review of the Eighth Edition of the American Joint Committee on Cancer Staging Guidelines, Prognostic Factors, and Histopathologic Variants. Adv Anat Pathol. 2017;24(4):171-94
  3. Ünal İ, Acar A. Skuamoz Hücreli Karsinom.Özkan AŞ, Akyol M, Editör. Dermatoonkoloji
  4. Baskı. İzmir: O’xxTIP Kitabevi; 2019:78-92
  5. Kallini JR, Hamed N, Khachemoune A. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends. Int J Dermatol. 2015;54(2):130-40
  6. Parekh V, Seykora JT. Cutaneous Squamous Cell Carcinoma. Clin Lab Med. 2017;37(3):503-25
  7. Work Group; Invited Reviewers, Kim JYS, Kozlow JH, Mittal B, Moyer J, Olenecki T, Rodgers P. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2018;78(3):560-578
  8. Tanese K. Diagnosis and Management of Basal Cell Carcinoma. Curr Treat Options Oncol. 2019;20(2):13
  9. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353(21):2262-9
  10. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994; 30:774-8
  11. Zanetti R, Rosso S, Martinez C, Nieto A, Miranda A, Mercier M, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multiCentre case-case-control study. Br J Cancer. 2006;94:743–51 11. Boonchai W, Green A, Ng J, Dicker A, Chenevix-Trench G. Basal cell carcinoma in chronic arsenicism occurring in Queensland, Australia, after ingestion of an asthma medication. J Am Acad Dermatol. 2000;43:664–9
  12. Watt TC, Inskip PD, Stratton K, Smith SA, Kry SF, Sigurdson AJ, et al. Radiation-related risk of basal cell carcinoma: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2012;104:1240–50
  13. Silverberg MJ, Leyden W, Warton EM, Quesenberry CP Jr, Engels EA, Asgari MM. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013;105:350–60
  14. Walling HW, Fosko SW, Geraminejad PA, Whitaker DC, Arpey CJ. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev 2004;23:389-402
  15. NCCN.org [homepage on the internet]. Pennsylvania: National Comprehensive Cancer Network. Basal cell skin cancer [Version 1.2020-October 24,2019]. Avai